Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults

Abstract

Compared with other medications, Beers criteria medications caused low numbers of and few risks for emergency department visits for adverse events. Performance measures and interventions targeting warfarin, insulin, and digoxin use could prevent more emergency department visits for adverse events.

Inappropriate Medication in a National Sample of US Elderly Patients Receiving Home Health Care

“…While our estimate of PIM use based on the Beers List provides a useful indicator of prescription quality, the Beers List does not include a number of medications that are commonly associated with serious adverse events (e.g, warfarin, insulin, and digoxin). 20 In addition, medications contraindicated by the Beers List may be appropriate and safe for a small proportion of patients. Although the 2007 NHHCS collected data on patient emergent care and hospitalization since admission to home care, we were not able to assess the extent to which PIM use had led to these adverse events.…”

Design and rationale for a randomized controlled trial to reduce readmissions among patients with depressive symptoms

“…Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), Myocardial Infarction (MI)) [5][6][7][8][9][10][11][12]. Functional decline associated with chronic medical illness is often accompanied by depressive symptoms, which arise in 20% to 50% of chronically ill persons [13][14][15][16].…”

Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements

“…Among patients over 65 years of age, warfarin is one of three drugs responsible for approximately one-third of adverse drug events treated in the emergency room. 2 In addition, US death certificates reviewed by Wysowski et al 1 indicate that between 2003 and 2004, anticoagulants were the leading cause of death among drugs that cause adverse effects. These statistics can be attributed to the high interindividual variability in warfarin dosing requirements and the combination of genetic and non-genetic factors that contribute to an individual's sensitivity to the medication.…”